116 related articles for article (PubMed ID: 34693691)
1. [An effect of 3-oxypyridine and succinic acid derivatives on the time of reduction of anxiety and depression symptoms in alcohol withdrawal treatment].
Volchegorskii IA; Izarovskii BV; Shamaeva TN; Izarovskaia IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):63-71. PubMed ID: 34693691
[TBL] [Abstract][Full Text] [Related]
2. [Anxiolytic and antidepressant effects of emoxipine, reamberin and mexidol in experimental diabetes mellitus].
Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Pryakhina KE
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):52-57. PubMed ID: 28638031
[TBL] [Abstract][Full Text] [Related]
3. [Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].
Volchegorskii LA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Pryakhina KE; Kalugina AV
Ross Fiziol Zh Im I M Sechenova; 2015 Mar; 101(3):258-67. PubMed ID: 26016320
[TBL] [Abstract][Full Text] [Related]
4. [Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales].
Lobo A; Chamorro L; Luque A; Dal-Ré R; Badia X; Baró E;
Med Clin (Barc); 2002 Apr; 118(13):493-9. PubMed ID: 11975886
[TBL] [Abstract][Full Text] [Related]
5. [Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in the acute phase of alloxan-induced diabetes in rats].
Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Faĭzullin RM; Malkin MP; Priakhina KE; Kalugina AV
Eksp Klin Farmakol; 2014; 77(4):14-20. PubMed ID: 25076754
[TBL] [Abstract][Full Text] [Related]
6. [Effect of 3-oxypyridine and succinic acid derivatives on affective status in recrudescence of inflammatory diseases of uterus and its appendages].
Volchegorskiĭ IA; Pravdin EV; Uzlova TV
Eksp Klin Farmakol; 2012; 75(11):22-7. PubMed ID: 23323329
[TBL] [Abstract][Full Text] [Related]
7. [Antidepressant effect of 3-oxypyridine and succinic acid derivatives (experimental study)].
Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Malkin MP; Faizullin RM; Pryakhina KE; Kalugina AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):48-52. PubMed ID: 26081324
[TBL] [Abstract][Full Text] [Related]
8. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS).
Svanborg P; Asberg M
J Affect Disord; 2001 May; 64(2-3):203-16. PubMed ID: 11313087
[TBL] [Abstract][Full Text] [Related]
9. [Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in experimental diabetes mellitus].
Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):50-61. PubMed ID: 23887452
[TBL] [Abstract][Full Text] [Related]
10. Effects of 3-hydroxypyridine derivatives and succinic acid on endometrial leukocyte infiltration, cytokinemia and related affective symptoms during exacerbation of the chronic inflammation of the uterus and adnexa.
Volchegorskii IA; Pravdin EV; Uzlova TV
Bull Exp Biol Med; 2014 Jan; 156(3):347-52. PubMed ID: 24771373
[TBL] [Abstract][Full Text] [Related]
11. [Depressive symptomatology and sleep apnea syndrome].
Pochat MD; Ferber C; Lemoine P
Encephale; 1993; 19(6):601-7. PubMed ID: 12404778
[TBL] [Abstract][Full Text] [Related]
12. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
[TBL] [Abstract][Full Text] [Related]
13. [Effect of 3-oxypyridine and succinic acid derivatives on endometrial leucocyte infiltration and lipid peroxidation in recrudescence of inflammatory diseases of the uterus and its appendages].
Volchegorskiĭ IA; Pravdin EV; Uzlova TV
Eksp Klin Farmakol; 2013; 76(3):13-8. PubMed ID: 23767097
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
Sheehan DV; Rozova A; Gossen ER; Gibertini M
Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
[TBL] [Abstract][Full Text] [Related]
16. Symptoms of depression and anxiety over time in chronic hemodialysis patients.
Bossola M; Ciciarelli C; Di Stasio E; Conte GL; Antocicco M; Rosa F; Tazza L
J Nephrol; 2012; 25(5):689-98. PubMed ID: 22009936
[TBL] [Abstract][Full Text] [Related]
17. [Dopaminergic potential of domestic 3-hydroxypyridine and succinic acid derivatives and prospects for their therapeutic «retargeting»].
Volchegorskii IA; Rassokhina LM; Miroshnichenko IU
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8):21-29. PubMed ID: 37655406
[TBL] [Abstract][Full Text] [Related]
18. Compared efficacy of prazepam and clomipramine in major depression with anxiety: a multicenter controlled study.
Lemoine P; Boulenger JP; Caillard V; Tanne N; Bonnet D
Pharmacopsychiatry; 1991 Sep; 24(5):175-9. PubMed ID: 1775523
[TBL] [Abstract][Full Text] [Related]
19. A study of the psychometric properties of the Beck Depression Inventory-II, the Montgomery and Åsberg Depression Rating Scale, and the Hospital Anxiety and Depression Scale in a sample from a healthy population.
Kjaergaard M; Arfwedson Wang CE; Waterloo K; Jorde R
Scand J Psychol; 2014 Feb; 55(1):83-9. PubMed ID: 24256317
[TBL] [Abstract][Full Text] [Related]
20. Effect of levetiracetam on depression and anxiety in adult epileptic patients.
Mazza M; Martini A; Scoppetta M; Mazza S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):539-43. PubMed ID: 18031881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
